Sign In
Buy TCON
$0.0322
+0 (+0%)
At Close: Oct 15, 2025
TRACON Pharmaceuticals, Inc. (TCON) Q3 2023 Earnings Call Transcript
09:10pm, Thursday, 09'th Nov 2023
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q3 2023 Results Conference Call November 9, 2023 4:30 PM ET Company Participants Dr. Charles Theuer - President and CEO Scott Brown - CFO Conference Call Pa
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
04:02pm, Thursday, 09'th Nov 2023
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pla
TRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023
04:02pm, Tuesday, 31'st Oct 2023
SAN DIEGO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pla
Full ENVASARC accrual expected in Q4 and final data expected in mid-2024 Full ENVASARC accrual expected in Q4 and final data expected in mid-2024
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
04:02pm, Tuesday, 05'th Sep 2023
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pl
7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole
07:20am, Friday, 25'th Aug 2023
Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product.
TRACON Pharmaceuticals, Inc. (TCON) Q2 2023 Earnings Call Transcript
06:50pm, Monday, 14'th Aug 2023
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q2 2023 Earnings Call August 14, 2023 4:30 PM ET Company Participants Charles P. Theuer - President and CEO Scott B.
Penny Stocks To Buy Now? 3 With Ratings Up To 1,742%
10:48am, Thursday, 03'rd Aug 2023
In a stock market characterized by growing unpredictability, traders are leaning on every possible resource. One such indispensable tool, whether dealing with penny stocks or more expensive shares, is
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
04:05pm, Wednesday, 02'nd Aug 2023
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pla
TRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference
08:00am, Friday, 16'th Jun 2023
SAN DIEGO, June 16, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted
TRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference
08:00am, Friday, 02'nd Jun 2023
SAN DIEGO, June 02, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted
TRACON Pharmaceuticals, Inc. (TCON) Q1 2023 Earnings Call Transcript
10:18pm, Wednesday, 10'th May 2023
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Charles Theuer - CEO, President & Director Scott Brown - CFO Conference Call P
Why Is TRACON Pharma (TCON) Stock Down 51% Today?
09:11am, Tuesday, 25'th Apr 2023
TRACON Pharmaceuticals (NASDAQ: TCON ) stock is falling on Tuesday following an update on a legal battle with I-Mab (NASDAQ: IMAB ). The bad news for TCON stock comes from a legal ruling favoring I-
Tracon (TCON) Moves to Buy: Rationale Behind the Upgrade
01:44pm, Tuesday, 14'th Mar 2023
Tracon (TCON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TRACON Pharmaceuticals, Inc. (TCON) Q4 2022 Earnings Call Transcript
08:00pm, Wednesday, 08'th Mar 2023
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants Charles Theuer - CEO, President & Director Scott Brown - CFO Conference Call
